Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Pancreatic Duct Adenocarcinoma”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Very early researchStudy completedNCT02153450
What this trial is testing

Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
Case Comprehensive Cancer Center 8
Early research (Phase 1)Not Yet RecruitingNCT06913218
What this trial is testing

MRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC

Who this might be right for
Pancreas CancerPancreas Cancer, Duct Cell Adenocarcinoma
Akeso 60
Testing effectiveness (Phase 2)Study completedNCT02959879
What this trial is testing

Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma

Who this might be right for
Resectable Pancreatic Duct Adenocarcinoma
University Hospital, Rouen 153
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Not applicableStudy completedNCT05025371
What this trial is testing

The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreas Cancer, Duct Cell Adenocarcinoma
Iuliu Hatieganu University of Medicine and Pharmacy 312
Testing effectiveness (Phase 2)Ended earlyNCT02243007
What this trial is testing

Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer

Who this might be right for
Resectable Pancreatic CancerPancreatic Ductal Carcinoma
Massachusetts General Hospital 7
Very early researchStudy completedNCT01821612
What this trial is testing

Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Alliance for Clinical Trials in Oncology 23
Early research (Phase 1)Ended earlyNCT01739439
What this trial is testing

Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage IIB Pancreatic Cancer+1 more
Fox Chase Cancer Center 6
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableNot Yet RecruitingNCT06670547
What this trial is testing

Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography

Who this might be right for
CholedocholithiasisCholedocholithiasis With Acute CholangitisCholangiocarcinoma+4 more
Germans Trias i Pujol Hospital 3,000
Testing effectiveness (Phase 2)Study completedNCT05262855
What this trial is testing

Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma

Who this might be right for
PDAC - Pancreatic Ductal AdenocarcinomaFAP
SOFIE 63
Not applicableNot Yet RecruitingNCT07034703
What this trial is testing

Prospective Cohort of Patients Treated Using Neoadjuvant Modified FOLFIRINOX 6 Cycles for Potentially Resectable Pancreatic Duct Adenocarcinoma, Candidate for Participation in the PANACHE02 Clinical Trial

Who this might be right for
Resectable Pancreatic Duct Adenocarcinoma
University Hospital, Rouen 820
Not applicableEnded earlyNCT02166190
What this trial is testing

RFA RCT for Pancreatic or Bile Duct Cancer

Who this might be right for
Unresectable Pancreatic CancerCholangiocarcinoma Non-resectable
Weill Medical College of Cornell University 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06573398
What this trial is testing

Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC

Who this might be right for
Carcinoma, Pancreatic Ductal
Ruijin Hospital 20
Not applicableUnknownNCT03063554
What this trial is testing

EUS BD vs ERCP TP for Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic AdenocarcinomaBiliary Tract Neoplasms+4 more
Weill Medical College of Cornell University 120
Not applicableStudy completedNCT04596865
What this trial is testing

Recurrence After Whipple's (RAW) Study

Who this might be right for
Pancreatic CancerAmpullary CancerBile Duct Cancer+11 more
University Hospital Plymouth NHS Trust 1,484
Not applicableUnknownNCT05489458
What this trial is testing

Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy

Who this might be right for
Carcinoma, Pancreatic Ductal
BUSQUETS, JULI 100
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Not applicableLooking for participantsNCT03823144
What this trial is testing

Intravital Microscopy in Human Solid Tumors

Who this might be right for
Solid Tumor, AdultClinical Stage IV Gastric Cancer AJCC v8Malignant Solid Neoplasm+20 more
Mayo Clinic 85
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Next Page